BAYER A.G. (BAYZF)
Clinical trial NCT03588299 updates: 1. completion date: 2026-11-03 → 2026-09-15 2. primary completion date: 2026-11-03 → 2026-09-15
Clinical trial NCT03588299 updates: 1. completion date: 2026-11-03 → 2026-09-15 2. primary completion date: 2026-11-03 → 2026-09-15
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical